PRVA logo

Privia Health Group Inc. (PRVA)

$24.99

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on PRVA

Market cap

$3.19B

EPS

0.27

P/E ratio

94.7

Price to sales

1.13

Dividend yield

--

Beta

0.765494

Price on PRVA

Previous close

$25.26

Today's open

$25.01

Day's range

$24.07 - $25.37

52 week range

$18.92 - $28.82

Profile about PRVA

CEO

Parth Mehrotra

Employees

1226

Headquarters

Arlington, VA

Exchange

Nasdaq Global Select

Shares outstanding

127768286

Issue type

Common Stock

PRVA industries and sectors

Healthcare

Healthcare Providers & Services

News on PRVA

Privia Health Reports Strong Results in the 2025 Performance Year of the Medicare Shared Savings Program

Privia Health's Ten ACOs Delivered $374 Million in Total Medicare Savings Company Increases Full-Year 2026 Financial Guidance a ARLINGTON, Va., Nov. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its Accountable Care Organizations (ACOs) achieved shared savings of $374.0 million through the Medicare Shared Savings Program (MSSP) for the 2025 performance year, a 59.7% increase from 2024.

news source

GlobeNewsWire • an hour ago

news preview

How Much Upside is Left in Privia Health (PRVA)? Wall Street Analysts Think 29.22%

The average of price targets set by Wall Street analysts indicates a potential upside of 29.2% in Privia Health (PRVA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

news source

Zacks Investment Research • Nov 10, 2026

news preview

3 Reasons Why Growth Investors Shouldn't Overlook Privia Health (PRVA)

Privia Health (PRVA) could produce exceptional returns because of its solid growth attributes.

news source

Zacks Investment Research • Nov 10, 2026

news preview

Privia Health Group Q3 Earnings Call Highlights

Privia Health Group NASDAQ: PRVA raised its 2026 financial outlook after reporting growth in providers, patient attribution and adjusted earnings through the first nine months of the year. The company also announced a $36 million acquisition that will expand its Medicare value-based care footprint in 2027.

news source

MarketBeat • Nov 6, 2026

news preview

Privia Health Group, Inc. (PRVA) Q3 2026 Earnings Call Transcript

Privia Health Group, Inc. (PRVA) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 5, 2026

news preview

Privia Health Reports Strong Third Quarter and Year-to-Date 2026 Results

Privia Health Reports Strong Q3 and YTD 2026 Results - Adjusted EBITDA of $114.7M, +21.9% from YTD'25 – FY'26 Guidance Raised for All Key Financial Metrics

news source

GlobeNewsWire • Nov 5, 2026

news preview

Privia Health (PRVA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Privia Health (PRVA) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

news source

Zacks Investment Research • Nov 5, 2026

news preview

Privia Health (PRVA) Q3 Earnings and Revenues Top Estimates

Privia Health (PRVA) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.05 per share a year ago.

news source

Zacks Investment Research • Nov 5, 2026

news preview

Privia Health Expands VBC Footprint with Acquisition of American Choice Healthcare MSSP Business

ARLINGTON, Va., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the acquisition of American Choice Healthcare MSSP, LLC (ACH), a wholly-owned subsidiary of Cano Health.

news source

GlobeNewsWire • Nov 2, 2026

news preview

Privia Health Group: Operating Leverage Could Lead To Share Price Upside

Privia Health Group is rated BUY, supported by strong operating leverage and expanding value-based care, positioning for earnings upside. PRVA trades at a 48% discount to its five-year average forward EV/EBITDA, with 24% forward EBITDA growth, outpacing peers. 2Q26 results showed 15% care margin growth, 29% adjusted EBITDA growth, and robust provider and patient expansion, highlighting operating efficiency.

news source

Seeking Alpha • Oct 22, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Privia Health Group Inc.

Open an M1 investment account to buy and sell Privia Health Group Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in PRVA on M1